Arrhythmia Discrimination via Localized R-R Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter-defibrillators (ICDs) face challenges in accurately discriminating between different types of arrhythmias, leading to inappropriate therapy delivery, particularly in patients with ventricular tachycardia and supraventricular tachycardia, due to reliance on heart rate alone and limited ability to distinguish between exercise-induced and arrhythmia-related heart rate increases.
Innovation Solution
The use of multiple sensing vectors to obtain intracardiac electrograms (IEGMs) from various regions of the heart, allowing for the determination of evoked response metrics and R-R interval stability, which enables more precise arrhythmia discrimination through the analysis of localized cardiac function and activation patterns, and the delivery of targeted therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple sensing vectors and evoked response metrics are used to improve arrhythmia discrimination accuracy, then measurement precision improves, but device complexity increases
Solution Approach 1:
The patent segments the ventricular chamber into multiple discrete regions (e.g., apical, mid-ventricular, basal segments) and places sensing electrodes at each segment. This segmentation allows independent measurement of evoked response metrics at each location, enabling precise localization of arrhythmia origins while maintaining a modular device structure that manages complexity through systematic regional division.
Solution Approach 2:
The patent transitions from single-point heart rate monitoring to multi-dimensional spatial mapping of electrical activation across the ventricular wall. By measuring evoked response metrics (amplitude, duration, morphology) at multiple spatial locations simultaneously, the system creates a three-dimensional characterization of cardiac electrical activity, enabling discrimination of arrhythmia types based on spatial patterns rather than scalar rate values.
2Measurement precision
If multiple sensing vectors are used to obtain IEGMs from various regions, then arrhythmia characterization accuracy improves, but the quantity of data processing increases
Solution Approach 1:
The patent extracts specific diagnostic features from the multi-channel IEGM data, focusing on key evoked response metrics such as amplitude, duration, and morphology at each electrode site. Rather than processing all raw signal data, the system identifies and extracts only the relevant characteristics needed for arrhythmia discrimination, significantly reducing data processing requirements while maintaining diagnostic accuracy.
Solution Approach 2:
The patent implements a hierarchical analysis approach where basic arrhythmia discrimination is performed using a subset of electrodes and simplified metrics, with more comprehensive multi-electrode analysis activated only when needed for ambiguous cases. This partial application of full-capability processing reduces routine data processing volume while maintaining the option for exhaustive analysis when clinically necessary.
Data Source
AI summary
Described herein are implantable systems and devices, and methods for use therewith, that can be used to perform arrhythmia discrimination. A plurality of different sensing vectors are used to obtain a plurality of different IEGMs, each of which is indicative of cardiac electrical activity at a different ventricular region. The plurality of different IEGMs can include, e.g., an IEGM indicative of cardiac electrical activity at a first region of the patient's left ventricular (LV) chamber and an IEGM indicative of cardiac electrical activity at a second region of the patient's LV chamber. Additionally, the plurality of different IEGMs can further include an IEGM indicative of cardiac electrical activity at a region of a patient's right ventricular (RV) chamber. For each of the IEGMs, there is a determination of a corresponding localized R-R interval stability metric indicative of the R-R interval stability at the corresponding ventricular region. This can include, e.g., determining, for each of the IEGMs, a plurality of R-R intervals corresponding to a plurality of consecutive cardiac cycles of the IEGM. For each IEGM, a measure of variation (e.g., standard deviation, range or variance, but not limited thereto) can then be determined for the plurality of R-R intervals to thereby determine the localized R-R interval stability metric for the IEGM. Arrhythmia discrimination is then performed using the plurality of determined localized R-R interval stability metrics.